收藏切换
Mining and analysis of cardiac adverse events and death cases of epidermal growth factor receptor inhibitors based on FAERS database
收藏切换
PDF
Hui-jie DENG1, 2, Li LIANG2, Yan CHEN2, Yu-hang GUO2, Jin-min GUO2, Bing LI2, Xiao-jian LIU1
Chinese Journal of New Drugs | 2023, 32(8) : 858 - 864
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(8): 858-864
Mining and analysis of cardiac adverse events and death cases of epidermal growth factor receptor inhibitors based on FAERS database
Full
Hui-jie DENG1, 2, Li LIANG2, Yan CHEN2, Yu-hang GUO2, Jin-min GUO2, Bing LI2, Xiao-jian LIU1
Affiliations
  • 1Department of Pharmacology, Basic Medical College of Jinzhou Medical University, Jinzhou 121001, China
  • 2Clinical Pharmacy Department, The 960th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Jinan 250000, China
Published: 2023-04-30
Outline
收藏切换
Objective:

To retrospectively analyze the cardiac adverse events and death cases of EGFR inhibitors through data mining of FDA adverse reaction reporting system (FAERS), so as to better understand the safety of EGFR inhibitors.

Methods:

The data in a total of 36 quarters in FAERS database from 2013 to 2021 were mined and analyzed by reporting odds ratio (ROR).

Results:

A total of 30 728 493 adverse events were reported in FAERS database from 2013 to 2021, including 735 693 cardiac adverse events. The effective signals were cetuximab [ROR=1.16, 95%CI (1.07,1.26)], rituximab [ROR=2.94, 95%CI (1.61,5.36)], dactinib [ROR=3.73, 95%CI (2.10,6.62)], and ositinib [ROR=1.55, 95%CI (1.44,1.66)]. McAbs were more likely to cause tachycardia. All heart-related effective signals of TKIs contained pericardial effusion. The significant death signals were panizumab [ROR=1.71, 95%CI (1.54,1.89)], gefitinib [ROR=2.93, 95%CI (2.64,3.25)], erlotinib [ROR=6.72, 95%CI (6.54,6.91)], afatinib [ROR=1.30, 95%CI(1.17,1.45)], dactinib [ROR=14.24, 95%CI (11.27,17.99)], and ositinib [ROR=15.03, 95%CI (14.53,15.54)].

Conclusion:

EGFR receptor inhibitors can cause adverse cardiac events with serious outcomes and increase the risk of death, which are worthy of clinical attention. Due to the limitations of database and detection methods, long-term data are still needed to verify these results to further understand the safety of EGFR inhibitors.

FAERS database  /  epidermal growth factor receptor inhibitor  /  cardiac adverse events  /  death  /  data mining
Hui-jie DENG, Li LIANG, Yan CHEN, Yu-hang GUO, Jin-min GUO, Bing LI, Xiao-jian LIU. Mining and analysis of cardiac adverse events and death cases of epidermal growth factor receptor inhibitors based on FAERS database[J]. Chinese Journal of New Drugs, 2023 , 32 (8) : 858 -864 .
Year 2023 volume 32 Issue 8
PDF
27
11
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-06
  • Published:2023-04-30
Article Data
Affiliations
History
  • Accepted:2022-06-30
Affiliations
    1Department of Pharmacology, Basic Medical College of Jinzhou Medical University, Jinzhou 121001, China
    2Clinical Pharmacy Department, The 960th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Jinan 250000, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT